tradingkey.logo
搜索

Biote Corp

BTMD
添加自选
2.250USD
+0.030+1.35%
收盘 07-31 16:00美东报价延迟15分钟
69.03M总市值
4.47市盈率 TTM

关于 Biote Corp 公司

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

Biote Corp简介

公司代码BTMD
公司名称Biote Corp
上市日期Mar 02, 2021
CEOChristensen (Bret)
员工数量217
证券类型Ordinary Share
年结日Mar 02
公司地址1875 W. Walnut Hill Ln #100
城市IRVING
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编75038
电话19724869346
网址https://haymakeracquisition.com/
公司代码BTMD
上市日期Mar 02, 2021
CEOChristensen (Bret)

Biote Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Mr. Robert (Bob) Peterson
Mr. Robert (Bob) Peterson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Mr. Richard R. (Rich) Barrera
Mr. Richard R. (Rich) Barrera
Independent Director
Independent Director
--
--
Ms. Debra L. Morris
Ms. Debra L. Morris
Independent Director
Independent Director
--
--
Ms. Dana Jacoby
Ms. Dana Jacoby
Independent Director
Independent Director
--
--
Dr. S. Mark Cone
Dr. S. Mark Cone
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Mr. Robert (Bob) Peterson
Mr. Robert (Bob) Peterson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Mr. Richard R. (Rich) Barrera
Mr. Richard R. (Rich) Barrera
Independent Director
Independent Director
--
--

常见问题

Biote Corp的前五大股东是谁?

Biote Corp 的前五大股东如下:Mr. Andrew R. (Andy) Heyer

有多少机构持有Biote Corp(BTMD)的股份?

截至2026Q1,共有214家机构持有Biote Corp的股份,合计持有的股份价值约为20.55M,占公司总股份的64.13%。与2025Q4相比,机构持股有所增加,增幅为-2349533.00。

哪个业务部门对Biote Corp的收入贡献最大?

在2026Q1,Pellet Procedures业务部门对Biote Corp的收入贡献最大,创收137.04M,占总收入的71.29%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有